Dual Stem Cell Treatment Restores Vision in First Human Trial
A revolutionary dual stem cell scaffold has successfully improved vision and eye surface scores in a small first-in-human clinical trial for aniridia-related keratopathy. For individuals suffering from ARK, progressive damage to the eye’s surface gradually clouds the cornea and severely compromises sight. Conducted jointly at Moorfields Eye Hospital and University College London (UCL), the groundbreaking … Read more